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Chapter 1
Introduction
Genetic information is encoded in deoxyribonucleic acid (DNA), a double-
stranded polymer of four bases (adenine (A), thymine (T), guanine (G) and cytosine
(C)). The two strands are paired by hydrogen bonding between A-T and G-C
base pairs (bp) [1]. The human genome consists of approximately three billion
bp within 23 chromosomes altogether containing ∼2 m of linear DNA. In order
to ﬁt into a ∼10 μm diameter nucleus, DNA must be folded and packaged into
a highly organized structure, the fundamental unit of which is the nucleosome.
Nucleosomes form the basic structure of chromatin. Histones H2A, H2B, H3 and
H4 serve as a scaffold and regulatory proteins; winding up DNA into arrays of
particles called nucleosomes [2]. Histones are positively charged and bind tightly
to the negatively charged DNA [3]. Each nucleosome wraps ∼1.7 turns, or ∼146
bp, of DNA in an array of repeats [4] that appear as ’beads on a string’ by electron
microscopy [5]. Nucleosomes are spaced by the linker histone H1 or its variant
histone H5 [2, 4].
Approximately 2% of the DNA consists of protein-coding genes [6]. However,
the intergenic regions encode functional non-coding ribonucleic acid (ncRNA) [7]
and consist of other regulatory elements such as enhancers [8]. Enhancers can also
be found in the intragenic regions of genes [9]. Enhancers contribute to regulating
the strength of gene expression by interacting with promoters, which are spatially
restricted regions around the transcription start site (TSS) of genes [8] (Figure 1).
As we will address later in this thesis, promoters and enhancers harbor many com-
binations of epigenetic modiﬁcations which affect their activity, their interaction
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with transcriptional regulators and their localization in the nucleus. The end-result
of these modiﬁcations is a tightly regulated spatial and temporal regulation of gene
expression, driving developmental and cell differentiation programs and cell and
tissue homeostasis.
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Figure 1: Schematic annotation of the genome into genes, promoters, enhancers and intergenic
regions.
1.1 Epigenetic regulation of chromatin function and
conformation
Epigenetics refers to the study of processes taking place “on top of” (epi- in
Greek) the DNA code: these processes consist of heritable biochemical modiﬁc-
ations of DNA or chromatin which affect gene expression but not the underlying
DNA sequence [10]. Epigenetics represents a “link” between genotype and phen-
otype. The outcome of a particular gene (repressed or expressed at various levels)
is represented in Waddington’s epigenetic landscape proposed in 1957 (Figure 2).
The notion is that a cell makes numerous decisions while differentiating and these
decisions lead to a particular cell fate producing a particular cell type. In the last
two decades, many factors contributing to epigenetic regulation of gene expres-
sion have emerged and are increasingly being understood.
1.1.1 Post-translational modiﬁcations of histones
Histones are subject to numerous post-translational modiﬁcations (PTMs). PTMs
are found in the globular domain and in the ﬂexible N-terminal tail of all his-
2
Figure 2: Waddington’s Classical Epigenetic Landscape. This is the metaphorical visualization of
a cell (represented by the ball) capable of taking different permitted trajectories leading to speciﬁc
outcomes in cell fate. Figure taken from [11].
tones. PTMs include acetylation and methylation of lysines (K) [12] and arginines
(R) [13, 14], phosphorylation of serines (S) [15] and threonines (T) [16], ubi-
quitylation and sumoylation of lysines [17], and β-N-acetylglucosamination of
serines and threonines [18] (Figure 3). Additional PTMs include ADP ribosyla-
tion, ubiquitination, deamination, proline isomerisation, biotinylation and cleav-
age of the histone tails [19–21].
Acetylation on lysine residues is generally coupled to a transcriptionally per-
missive state, probably by neutralizing the basic charge of lysines in the N-terminal
tail of histone H3 and H4, relaxing DNA-histone interactions or histone-histone
interactions. In contrast, mono- and di-methylation of arginine and mono-, di-,
and tri-methylation of lysine can repress or activate transcription depending on
the residue modiﬁed [22]. Although considered as a mark of active genes, H3 lys-
ine 4 trimethylation (H3K4me3) occupies the promoter and TSS of many genes
irrespective of their transcriptional status [23] and thus should be regarded as a
promoter mark. Nonetheless, H3K4me3 has also been reported on gene bodies
in Arabidopsis [24], zebraﬁsh [24] and humans [25] in association with transcrip-
tional activity. H3K4me2 is more typically associated with transcriptionally active
sites in chromatin and shows a dynamic distribution on promoters, introns and in-
tergenic regions [26]. H3K4me1 has been found to mark enhancers regardless of
the expression status of their cognate genes [27]. Co-enrichment of H3K4me1
with acetylated H3K27 (H3K27ac) marks enhancers of active genes [27]. In con-
trast, in mammalian cells H3K27me3 is enriched on inactive promoters [28] but
can also be distributed broadly across inactive regions of the genome [29].
Many active histone PTMs associate with transcriptional complexes and RNA
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Figure 3: Nucleosomal histones and post-translational modiﬁcations on their N-terminal tails,
including methylation (Me), acetylation (Ac), ubiquitination (Ub), and phosphorylation (Ph). The
N-terminal tails of histone tend to protrude from the nucleosome core, making them accessible to
“writers” and “readers” of the epigenetic code. Adapted from [31].
polymerase II (RNAPII). While the H3K4 histone methyltransferase (HMT) SET1
is targeted to the 5’ end of genes through recruitment by the initiating serine
(Ser)5-phosphorylated RNAPII [30], the H3K36 HMT SETD2 associates with
the Ser2-phosphorylated elongating form of RNAPII. Hence, H3K4me3 marks
the TSS and 5’ end of genes, while H3K36me3 marks transcribing gene bodies
and the 3’ end of genes [29].
1.1.2 Combinations of histone modiﬁcations form “chromatin
states” that modulate transcription
Histone modiﬁcations modulate transcription outcome by regulating the chro-
matin conformation or by blocking or recruiting transcriptional regulators. His-
tone PTMs can lead to varying degrees of chromatin compaction. The relatively
“open” chromatin conformation is referred to as euchromatin – which appears as
electron-light by electron microscopy, whereas the compact form of chromatin is
referred to as heterochromatin – appearing as electron-dense in the electron mi-
croscope (Figure 4). Euchromatin is overall gene-rich (i.e. its gene density is
4
Figure 4: Electron micrograph of oligodendroglial satellites of neuron in the prefrontal cortex of
the brain. Heterochromatin appears more electron-dense (darker) than euchromatin and tends to
be located near the nuclear periphery. Abbreviations: N, nucleus; H, heterochromatin; E, euchro-
matin; Neu, neuron; M, mitochondria; R, reticulum; Rib, ribosomes. Taken from [45]
higher than that of the genome average gene density of ∼8 genes/megabase (Mb)
in humans). Heterochromatin in contrast is gene-poor and mostly contains tran-
scriptionally inactive protein-coding genes [32–34]. Increasing evidence indic-
ates however that many genes encoding ncRNAs are transcribed from heterochro-
matic regions [35–37]. Heterochromatin is predominantly found in telomeres,
centromeres and pericentromeric regions [38, 39]. These domains are marked
by distinct histone PTMs and are differentiated by boundary elements often re-
ferred to as insulators [40]. Heterochromatin is characterized by H3K9me3 and
its effector protein heterochromatin protein 1 (HP1/CBX3) [41]. However, the
ﬁnding of H3K9me3 and HP1 in coding regions of transcribed genes has chal-
lenged the view of H3K9me3 as a strict marker of heterochromatin [42]. This
shows the importance of genomic context on the transcriptional outcome of his-
tone PTMs. Another mark of heterochromatin is H4K20me3, enriched in repeat
regions [38, 43, 44]. Heterochromatin is further characterized by a lack of histone
acetylation, H3K4me2/3 or H3K36me2/3 [42]. In contrast, euchromatin is char-
acterized by promoter H3K4me3, H3K36me3 on active gene bodies, H3K79me3
and various forms of lysine acetylation [22].
The advent of DNA high-throughput sequencing (HTS) technologies down-
stream of chromatin immunoprecipitation (ChIP), a technique referred to as ChIP-
seq (see section 1.4.1) of modiﬁed histones and transcription regulators, chromatin
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landscapes have started to emerge. Data from Drosophila reveal no less than ﬁve
main “chromatin states” enriched in speciﬁc combinations of 53 chromatin bind-
ing proteins [46]. Additional studies have similarly identiﬁed a number of distinct
chromatin states and have attributed these states to biological functions (e.g. act-
ive, poised, repressed domains) [47, 48]. Interestingly, combining histone PTMs
with RNAPII binding data enables prediction of the activity level of regulatory
regions during development [49]. As discussed later (section 1.5), bioinformatics
methods have enabled biological functions to be ascribed to epigenetic modiﬁca-
tions.
1.1.3 A relationship between cellularmetabolism and chromatin
organization?
Cell metabolism is coupled to histone PTMs and to the activity of chromatin re-
modeling proteins affecting chromatin structure and gene expression [50]. Meta-
bolic intermediates often act as co-factors or substrates of histone modifying en-
zymes. Of importance for work presented in this thesis (Paper II), the hexosa-
mine biosynthetic pathway (HBP) is responsive to intracellular levels of amino
acids, fatty acids and carbohydrates [51] and constitutes an important link between
glucose metabolism and chromatin. Approximately 3-5% of glucose taken up by
the cell is directed to the HBP [52] and converted to UDP-N-acetylglucosamine
(UDP-GlcNAc), the donor of O-linked GlcNAc for O-GlcNAcylation of proteins.
GlcNAcylation is catalyzed by the O-GlcNAc transferase OGT [53], while O-
GlcNAcase (OGA) hydrolyzes O-GlcNAc [54, 55]. All core histones can be
GlcNAcylated [56–58], indicating that chromatin organization is inﬂuenced by
the OGT/OGA balance.
GlcNAcylation of H2B on Ser 112 (H2BS112GlcNAc) has been reported in
mammalian cell lines at the TSS of transcribed genes [18,59,60]. H2BS112GlcNAc
has also been claimed to promote H2BK120 monoubiquitination (H2BK120ub1)
in HeLa cells, suggesting a link to gene activity [18]. However inDrosophila cells,
OGT has been linked to transcriptional repression [61]. In Drosophila, OGT is a
Polycomb Group protein essential for Polycomb-mediated gene repression during
development [61, 62]. OGT also modiﬁes proteins involved in transcriptional re-
pression [63]. For instance, GlcNAcylation of the Polycomb repressor complex
6
2 protein EZH2 (which methylates H3K27) regulates EZH2 protein stability, and
H3K27me3 partly depends on OGT expression [64]. Moreover, GlcNAcylation of
the SIN3A subunit of histone deacetylase HDAC1 has a repressive impact on gene
expression [65]. Thus, it is possible that H2B-S112GlcNAc plays distinct roles in
different cell types. It also emerges from these studies that the connection between
gene expression and H2BS112GlcNAc is still unclear. Moreover, positioning of
H2BS112 on the nucleosome surface raises the hypothesis that H2BS112GlcNAc
promotes other chromatin-associated processes. This is a key premise of Paper
II.
1.2 Towards understanding the 3D genome: associ-
ations of chromatin with nuclear lamins
The nuclear envelope contributes to deﬁning position, shape and functions of
the eukaryotic cell nucleus. The nuclear envelope consists of an outer and in-
ner nuclear membrane underlined in the nucleoplasmic side by an intermedi-
ate ﬁlament meshwork called the nuclear lamina [66–68]. Two types of nuc-
lear lamins make up the nuclear lamina: A-type lamins (lamins A and C, often
referred to as lamin A/C) which are splice variants of the LMNA gene, and B-
type lamins, consisting of lamins B1 and B2 encoded by the LMNB1 and LMNB2
genes respectively. B-type lamins are constitutively expressed and are anchored
to the inner nuclear membrane through a farnesylated CAXX motif in their C-
terminus [68]. In contrast, A-type lamins are developmentally regulated: they
are undetectable or expressed at low levels in early embryos and embryonic stem
cells but are expressed in more differentiated progenitors and terminally differ-
entiated cells [68–70] with a few exceptions [43]. As part of their maturation,
A-type lamins lose the C-terminal farnesylation site and thus do not anchor into
the inner nuclear membrane [68]. Instead, they associate with B-type lamins in
the peripheral nuclear lamina [71] and a pool of lamin A/C remains nucleoplas-
mic [72, 73].
The intranuclear fraction of lamin A/C depends on the nucleoplasmic pro-
tein lamina-associated polypeptide LAP2α which directly binds lamin A/C and
chromatin [74, 75]. Nucleoplasmic lamin A/C and LAP2α affect retinoblastoma
7
protein function [76] and promote cell cycle arrest in tissue progenitor cells [75,
77, 78], and LAP2α overexpression in mouse pre-adipocytes favors adipogenic
differentiation [79]. Nucleoplasmic lamin A/C appears therefore to be critical for
differentiation of tissue progenitor cells; they may also play a role in the regula-
tion of gene expression in the nuclear interior [73, 80]. Our laboratory and others
have notably shown that lamin A/C-genome interactions can also occur on pro-
moters [81, 82], suggesting a role of lamin A/C in gene regulation, perhaps in
the nuclear interior (which is gene-rich). Paper II reports a large-scale spatial
reorganization of chromatin during differentiation of human adipose tissue stem
cells into adipocytes, involving association/dissociation events of chromatin with
A-type lamins.
Presumably due to their ability to bind DNA and nucleosomes in vitro [83], A-
and B-type lamins associate with chromatin [84]. These contacts occur through
large lamina-associated domains – which for reasons apparent in Paper II we re-
name lamin-associated domains (LADs). LADs span 0.1 to 10 Mb [34, 84–91]
(Figure 5). LADs are generally conserved between cell types but some cell type-
speciﬁcity exists [92]. LADs are overall gene-poor and transcriptionally inact-
ive [86,92,93]. Accordingly, LADs are enriched in histone modiﬁcations charac-
terizing silent chromatin, including H3K9me2 or me3 [86,89–91]; this is consist-
ent with the heterochromatic environment of the nuclear periphery [43, 94–96].
Targeting and anchoring of loci at the nuclear periphery in C. elegans or mouse
cells requires H3K9me2/3, H3K27me3, lamin A/C (in mammals), short DNA se-
quences and protein factors [96–98]. This suggests that LAD formation is tightly
regulated in a temporal and cell type-speciﬁc manner.
Recent data from our laboratory and others [82,87,90,99] suggest that lamin-
chromatin interactions are under developmental control. Notably, in adipose tis-
sue stem cells (ASCs – a cell type we have used in our work), pro-adipogenic
gene promoters are released from lamin A/C after differentiation into adipocytes,
whereas many non-adipogenic, lineage-speciﬁc promoters remain associated with
lamin A/C [82]. Moreover, dissociation of a myogenic promoter from C. elegans
lamin has also been linked to muscle-speciﬁc gene activation [95]. These results
again argue that lamin-genome interactions may be under developmental regula-
tion. This aspect is examined at the genome-wide level in Paper II.
Nuclear lamins play an important role in the organization of heterochromatin
8
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Figure 5: Schematic Representation of a lamin-associated domain (LAD). LADs are mostly gene
poor and heterochromatic, and their borders are in some cases enriched in the insulator protein
CCCTC-binding factor CTCF and in H3K27me3.
[43, 82, 89–91, 99, 100] and impact spatial genome conformation [34]. Lamins
also anchor signaling molecules and transcription factors [101, 102] and connect
the nuclear interior with elements of the cytoskeleton [68] inﬂuencing the position
of cell nucleus [68, 103]. It is thus not surprising that mutations in nuclear lamins
and lamin A/C in particular cause diseases. More than 400 lamin A mutations
cause ∼15 diseases commonly called laminopathies, showing symptoms such as
partial lipodystrophies, myodystrophies, cardio-myopathies, skeletal abnormalit-
ies or premature aging (progeria) [66,102,104]. Pathways linking lamin mutations
to diseases are unknown but involve abnormalities in chromatin organization [95],
signal transduction [102,105] and autophagy [106].
A common feature of partial lipodystrophies caused by speciﬁc lamin A muta-
tions is metabolic disorders involving glucose intolerance and insulin resistance,
often leading to type II diabetes [107]. Remarkably, these syndromes are also
linked to alterations of the HBP pathway and O-GlcNAC cycling (see above)
due to HBP overactivity or mutations in OGA [50]. We rationalized in Paper
II that the common metabolic disorders caused by deregulation of protein O-
GlcNAcylation and lamin A-linked lipodystrophies might underline a relationship
between lamin A/C and chromatin modiﬁcations modulated by H2BS112GlcNAc.
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1.3 Regulation of the genome by 3-dimensional chro-
matin organization
1.3.1 Interactions between promoter and enhancer elements
regulate gene expression
Enhancers play a critical role in regulating the strength of gene expression and
the activity level of a promoter [108]. Enhancers typically consist of relatively
small genomic segments (a few hundred base pairs) that harbor binding sites for
protein complexes containing transcription regulators [8,109,110]. Enhancers ex-
ert their activity on promoters interacting with their cognate promoters through
looping of chromatin [108, 111]. The enhancer nearest to a promoter in the lin-
ear genome does not necessarily regulate or interact with that promoter. Indeed,
chromatin conformation capture (3C) studies and other techniques derived from
3C, such as chromatin interaction analysis with paired-end tag sequencing (ChIA-
PET), reveal that promoter-enhancer (P-E) interactions often occur over tens of
kilobases up to megabases apart in the linear genome [112]. Enhancers may even
loop over nearby promoters (and not interact with them) to make physical contact
with a more distant cognate promoter [112, 113]. In addition, an enhancer inﬂu-
encing a given gene can either be upstream or downstream of the gene. There-
fore, identifying which enhancer regulates activity of which promoter does not
merely imply searching for the nearest enhancer. Identifying P-E interactions in a
3-dimensional (3D) context is essential.
Several studies have attempted to identify criteria for interaction of an en-
hancer with a promoter, which have led to a general consensus of mechanisms
that may be responsible for mutual selectivity of interacting promoters and en-
hancers [113–116] (Figure 6). These mechanisms include biochemical compat-
ibility, spatial architecture, insulation and chromatin environment. Biochemical
compatibility (Figure 6A) refers to a condition where a given enhancer “E1” is
compatible with a promoter “P” while another enhancer “E2” is incompatible.
Spatial architecture (Figure 6B) refers to a situation where both E1 and E2 enhan-
cers are compatible with promoter P, but only E2 can interact due to the spatial
architecture it is in [117, 118]; for instance, a promoter may be in a different
topologically-associated domain (TAD; see also section 1.3.2) from an enhancer
10
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Figure 6: Distinct mechanisms can drive promoter–enhancer interaction speciﬁcity. (A) Biochem-
ical compatibility. (B) Spatial architecture. (C) Insulation. (D) Chromatin environment. See text
for details. Adapted from [8]).
it could potentially interact with, but it cannot interact because of physical con-
straints [116, 119]. However, interaction might, for instance, become possible
following a mutation causing a conformational switch. Recent evidence of single
nucleotide polymorphisms (SNPs) causing mutations also eliciting a switch in P-
E interaction support the spatial architecture model of P-E interaction [120, 121].
In the case of insulation (Figure 6C) as a factor affecting a P-E interaction, enhan-
cer E2 cannot interact with promoter P even though P and E2 are compatible, due
to the presence of an insulator element between the two (e.g. CTCF; see below).
Chromatin environment (Figure 6D) refers to epigenetic modiﬁcations at enhan-
cers, promoters and intervening sequences which may modulate P-E interactions.
Importantly, the chromatin context of enhancer E2 may also inﬂuence whether
promoter P and enhancer E1 can interact [122, 123].
Advances in HTS techniques (section 1.4) greatly facilitate the study of gen-
ome and chromatin architecture at the genome-scale level [124–126]. However,
generating genome-wide data for many cell types with high resolution remains ex-
haustive and expensive. Therefore, there is strong motivation to develop methods
to predict P-E interactions using existing information from chromosome interac-
tion and epigenomic datasets. In Paper III, we report an epigenetic pipeline to
identify P-E interactions in cell types for which chromosomal interaction data do
not exist.
1.3.2 CTCF
The CCCTC-binding factor CTCF [127] has been described as an insulator
element shown to be a key regulator of P-E interactions [113, 128]. It contains 11
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Figure 7: Proposed functions of CTCF. (I) CTCF-mediated chromatin loops contain active genes
(green boxes) and H3K4me1 in the loop region and inactive genes (red boxes) and repressive
marks such as H3K27me3 outside the loop. (II) Inactive genes and repressive marks inside the
loop and active genes outside the loop. (III) H3K36me3 outside the loop on one side. (IV) Active
genes and H3K4me1 outside the loop on one side and H3K27me3 outside the loop on the other
side. (V) Chromatin loops do not appear to contain any characteristic gene expression or histone
modiﬁcation patterns. Figure adapted from [135]
zinc-ﬁngers that constitute highly conserved DNA-binding domains [129]. CTCF
binds the mammalian genome at 55,000-65,000 sites [130]; of which ∼23,000
binding sites are constitutive in 123 ENCODE cell types [131], whereas 30-60%
are cell-type speciﬁc [132].
CTCF emerges as a key player in the spatial organization of the genome by or-
ganizing long-range chromosomal interactions (Figure 7). Circular chromosome
conformation capture (4C) studies indicate CTCF binding sites are required on
the H19 imprinting control region (ICR) to form inter- and intra-chromosomal in-
teractions [133]. CTCF binding at DNase I hypersensitivity sites is also required
to maintain chromatin architecture at the Hbb locus in mice [134]. CTCF is im-
portant in organizing spatial genome architecture (Figure 7). CTCF tethers DNA
strands on separate loci, thus forming CTCF-mediated chromatin loops. CTCF is
involved in the formation of chromatin loops to isolate active chromatin regions
from inactive ones and isolate regions with distinct chromatin states. These fea-
tures of CTCF constituted the premises for using CTCF binding data in our study
of P-E interactions (Paper III).
A role of CTCF as an insulator protein has emerged from studies suggesting
that CTCF acts as a barrier to prevent spreading of heterochromatin ‘seeded’ at
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silenced integrated transgenes [127]. CTCF however does not systematically insu-
late repressed chromatin domains: only 2-4% of H3K27me3 domain borders con-
tain CTCF in HeLa cells [132], and similarly, ∼9% of LAD borders in ﬁbroblasts
harbor CTCF [86]. CTCF also appears to be responsible for creating functional
gene expression domains in which CTCF loops contain marks of active chromatin
while repressive modiﬁcations are kept outside the loop [136]. CTCF may also
be involved in the establishment of chromatin domains where gene expression is
regulated in cohorts [137].
CTCF has also been characterized as an enhancer blocker [128, 138–141].
However, this seems to be at speciﬁc loci only [128, 138, 139]. CTCF may also
positively regulate P-E interactions [142–145]. Using chromosome conformation
capture carbon copy (5C), it has been shown that 79% of long range interactions
are not blocked by CTCF. However, a portion of the distal interactions are en-
riched in CTCF and/or enhancer marks [113]. CTCF-mediated interactions are
established between enhancers and their cognate promoters prior to transcriptional
upregulation [146,147] and ChIP-seq studies point to CTCF-mediated targeting of
cognate promoters by regulatory elements enriched in CTCF-binding sites [148].
Lastly, CTCF has been linked to the formation of topologically-associated
domain (TAD) borders [149–152]. However, with one study showing that only
15% of CTCF-binding sites are at TAD borders and 85% within the TADs [119].
Thus, CTCF within TADs might be responsible for blocking or facilitating intra-
TAD P-E interactions.
1.4 Sequencing Techniques to study genome-wide chro-
matin regulation
1.4.1 ChIP-seq
A plethora of proteins interact with DNA to regulate functions such as transcrip-
tion, DNA replication, DNA repair, chromosome organization. ChIP is to date, ar-
guably, the method of choice to identify genomic locations of these protein-DNA
interactions [153]. ChIP has been widely used to map the location of histone
PTMs, transcription factors (TFs) and other non-histone proteins which interact
13
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Figure 8: An outline of the ChIP protocol. The steps include DNA-protein cross-linking, cell
lysis, shearing of chromatin, immunoprecipitation with a speciﬁc antibody, DNA puriﬁcation and
mapping of precipitated DNA by various methods. Figure adapted from [157]
with chromatin (in)directly. Identiﬁcation of chromatin/DNA protein binding sites
can be conﬁned to speciﬁc genomic sites or extended to a genome-scale.
ChIP (Figure 8) consists in reversibly cross-linking DNA and proteins, most
commonly using formaldehyde. This maintains association between DNA and
proteins throughout the chromatin preparation and immunoprecipitation steps.
However, it is not necessary to cross-link DNA and proteins to investigate his-
tone PTMs (this is in the case called “native ChIP”) as DNA binds to histones
tightly [154, 155]. Chromatin is sheared to ∼200-500 bp fragments, insoluble
complexes are sedimented and resulting chromatin is used for immunoprecipit-
ation with an antibody against the protein of interest. The ChIPed material is
washed stringently, cross-linking is reversed by high temperature (68oC), proteins
are digested and ChIP DNA isolated. This DNA contains genomic segments in
contact with the protein of interest, which can be identiﬁed by polymerase chain
reaction (ChIP-PCR), hybridization to microarrays (ChIP-chip) or by HTS (ChIP-
seq) [156].
Various histone PTMs display distinct enrichment proﬁles throughout the gen-
ome [28,29,158,159]. Transcription factors typically display a sharp binding pat-
tern over a restricted genomic site and some histone PTMs (e.g. H3K4me3) tend
to display a narrow binding pattern. Thus, genomic enrichment of such proteins
can be identiﬁed without a sequenced control (reference) chromatin sample [160].
Typically however, a reference sample is required for proteins with wider binding
patterns because their enrichment level over a genome-average may not always be
prominent. Control samples for ChIP analyses can be cross-linked and fragmen-
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ted chromatin that is not subject to immunoprecipitation (“input” chromatin) or
ChIP using a non-speciﬁc antibody.
1.4.2 High-throughput sequencing-based techniques to study
chromatin organization in 3D
ChIP provides a snapshot of proteins bound to chromatin. However, alongside,
the 3D architecture of the genome plays an important role. 3C was invented by
Dekker and colleagues [161]. This method originally relied on quantiﬁcation by
PCR to assess interaction between two pre-determined genomic sites, but has in-
creasingly begun to be replaced by sequencing to provide a genome-wide view of
chromosomal interactions.
3C is a method to isolate DNA fragments in spatial proximity and in-turn
analyze interaction between two loci. Figure 9 illustrates the basics of 3C-based
technologies. The steps in 3C include cross-linking of DNA with formaldehyde.
Chromatin is then cut using a restriction enzyme which is chosen depending on
the level of resolution required as different restriction enzymes have different fre-
quencies of cuts along the genome and produce different fragment lengths [162].
The sticky ends of DNA are then re-ligated in extremely dilute conditions to avoid
ligation between DNA strands that are not interacting and favor intra-molecular
ligation. The resulting structure contains parts of both the DNA fragments that
were cross-linked. Finally, these hybrid DNA structures are quantiﬁed to generate
the number of interactions between DNA fragments [163–165]. However, 3C falls
short in genome-wide data analyses. Thus, an adaptation of the technique called
Hi-C where chromosomal interactions on a genome-wide scale can be studied
simultaneously is the data we have used in order to identify interactions (Paper
III).
Hi-C was introduced to quantify DNA interactions in an "all vs. all" fashion,
i.e. genome-scale chromosomal interactions (Figure 9) [166]. There is only one
additional step (after digestion) in Hi-C compared to 3C, in which the sticky DNA
ends are labeled with biotin-labeled nucleotides before purifying and shearing
DNA. The hybrid DNA molecules are puriﬁed by pulling down the biotin mark,
and ligated in dilute conditions. The resulting library consisting of hybrid DNA
is sequenced using paired-end sequencing. The mapping position of each mate in
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Figure 9: (A) First steps of a 3C protocol. (B) Schematic representation of the principles in various
3C based methods. Figure taken from [163]
the pair is used to generate a genome-wide aggregated contact matrix. Using Hi-
C, interactions in the human genome have been mapped at a resolution of 100 kb
[166] to 40 kb [119] and more recently 1 kb [167]. Hi-C has also been performed
on single cells, providing maps for individual cells instead of cell populations
[168]. Thus, Hi-C can provide chromatin-interaction information on a genome-
wide level.
Identiﬁcation of genomic interactions where the same protein is (in)directly
interacting with both loci requires ChIA-PET [169]. ChIA-PET combines ChIP-
seq and 3C to identify regions of DNA bound to the same protein Figure 9 [125].
In other words, it enables identiﬁcation of protein-mediated DNA-DNA interac-
tions. In the ChIA-PET approach, chromatin is fragmented by sonication after
crosslinking and processed for ChIP using an antibody against the protein of in-
terest (similar to ChIP-seq; Figure 8) [125]. Biotinylated DNA linkers added to
the ChIPed DNA fragment ends, containing Mme1 speciﬁc restriction sites. The
cross-links are reversed; digested with Mme1, and biotin-containing fragments are
sequenced by paired-end sequencing [164, 170]. Two ligation products are gen-
erated by ChiA-PET. One is self-ligations caused by self-circularization ligation
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of the same DNA fragment which leads to the reads being mapped close to each
other in the reference genome. These reads can be used as anchors of the interact-
ing chromatin segments. The second product is inter-ligations which are pairs of
reads further away from each other. These are quantiﬁed to generate interaction
frequencies between the anchors [120]. Thus ChIA-PET, unlike other 3C-based
methods, identiﬁes interactions in DNA where the same protein is bound.
1.4.3 RNA-seq
RNA-sequencing (RNA-seq) uses the power of sequencing to estimate the total
amount of RNA in cells [171]. For RNA-seq, isolated RNA is converted to a
library of cDNA fragments with adapters and the cDNA library ampliﬁed. Since
sequencing reads have a read length limit, RNA has to be fragmented into bits
of ∼200-500 bp. Fragmentation is done by either RNA fragmentation or cDNA
fragmentation. Each method has its own bias. Reads from RNA fragmentation
are depleted for the ends of the transcript whereas cDNA fragmentation is biased
towards the identiﬁcation of 3’ ends of transcripts. The resulting molecules can
be sequenced using either single-end sequencing or paired-end sequencing. The
sequenced reads can be mapped back to a reference genome or be assembled de
novo, providing a genome-wide map of transcript levels.
A subset of RNAs such as poly-adenylated (polyA) RNA, micro-RNA (miRNA)
[172–175] can be quantiﬁed using RNA-seq. MiRNA is a class of RNA which
are 21-25 nucleotides long and play a role in gene regulation by silencing genes
through RNA-induced silencing complex which contains Dicer and other asso-
ciated proteins [176–179]. In order to sequence miRNA, RNA is isolated based
on size by using a size exclusion gel, or using size selection magnetic beads.
On the other hand, mRNA require different steps prior to sequencing. A chain
of 100-250 adenines (polyA) are added to the 3’ end of mRNA after transcrip-
tion to make it more stable and prevent degradation [180]. PolyA RNA are ma-
ture mRNA which are transported from the nucleus to the cytoplasm to be trans-
lated. PolyA RNA can be captured using magnetic beads coated with polyT oli-
gonucleotides [173,181]. Separating mRNA with polyA tails from total RNA can
provide expression levels for coding genes and non-coding transcriptome separ-
ately. It has been noted that only about one ﬁfth of transcription in the human gen-
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ome is for protein-coding genes [182]. Studies have shown regulation of ncRNAs
during development [183, 184]. They also display cell-type speciﬁc expression
patterns [185, 186] and have shown to be associated with disease [187, 188]. In
our study, we have generated a dataset of total RNA as it can provide informa-
tion on protein-coding genes as well as non-coding RNA which might play an
important role in gene regulation.
It should be noted that RNA-seq is conceptually similar to Expressed Tag Se-
quencing (EST) (an application of Sanger sequencing). However, the fragments
to be sequenced have to be ∼200-500 bp in length. This generates complications
and biases speciﬁc to RNA-seq in regard to the length of the transcripts. Nonethe-
less, it is a massive step forwards from EST and microarray techniques. RNA-
seq provides single base resolution without the background noise of microarrays
caused by incorrect hybridization while also not requiring full knowledge of a ref-
erence genome. Using RNA-seq to quantify the raw sequences of the transcripts
present in the cells allows to study not only levels of transcripts but also altern-
ative splicing, mutations, fusion transcripts [189]. Thus, RNA-seq in conjunction
with ChIP-seq and 3C-based methods can provide decryption of the functionality
of the genome; these approaches have been exploited in this thesis.
1.5 High-throughput sequencing: methods and ana-
lysis
Each of the applications of the sequencing methods described in section 1.4,
such as ChIP-seq, Hi-C, ChIA-PET and RNA-seq, results in the generation of
different datasets with different properties and characteristics. Thus, a multitude
of tools and statistical methods have been developed to analyze results from such
data, using separate statistical methods for each data-type. In this section, the
main analysis methods and tools for the different technologies are assessed.
1.5.1 Sequence alignment to a reference genome
Sequencing data provides a list of short sequences whose original position in
the genome is unknown. The most probable location of the sequence can be iden-
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tiﬁed by mapping the sequence back to the appropriate reference genome. This
would be a straightforward task if the entire genomic sequence was unique. How-
ever, there are numerous regions with similar sequences such as repeat regions,
transposons, and gene paralogs. In addition, single nucleotide polymorphisms
(SNPs), where only one base pair is mutated, leads to variations between the
sequenced data and the reference genome. There is also a possibility of errors
in identifying bases during the sequencing process. However, the sequences are
often accompanied by scores providing accuracy estimates for each base that is
sequenced. Correspondingly, sequencing aligners have been developed to rapidly
and accurately map HTS data to a reference genome, taking the accuracy scores
into account.
Popular aligners used for mapping sequencing data are typically based on the
Burrows-Wheeler Transform (BWT) [190] and the FM (Ferragina-Manzini) in-
dex [191]. The BWT algorithm was originally developed to compress data, by
constructing a reversible permutation of the character sequences. The resulting
BWT allows for fast lookup of sequences in the database. The FM index iden-
tiﬁes exact matches and further builds inexact alignments supported by the exact
matches found using a sufﬁx tree. The advantage provided is that substrings of
the sequence with multiple copies in the reference genome need to be aligned only
once and later collapse into one path as the algorithm traverses the tree. There are
more than 60 sequence mappers developed [192] of which Bowtie2 [193] and
BWA [194] are popular choices based on the FM index because they are fast and
computationally efﬁcient. Sequence alignment is the basic step used in processing
of HTS data and is followed by speciﬁc analyses.
1.5.2 ChIP-seq analysis
ChIP-seq has been used to identify binding patterns of TFs and histone PTMs.
TFs and most histone modiﬁcations like H3K4me3 (Figure 10, red) have a nar-
row chromatin-binding region, whereas H3K27me3 and H3K36me3 (Figure 10,
green) are usually wider [195–197]. Enriched regions are identiﬁed using peak
callers. The most common peak caller used for TFs and histone modiﬁcations
is MACS [198]. MACS takes advantage of observed bimodal enrichment pat-
terns by empirically modeling the shift size. It takes into account that there are
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local biases in the genome by modeling the local background using a dynamic
Poisson distribution. It identiﬁes peaks with a P-value lower than 10-5 (default)
which can be tweaked to a lower value for sharp binding patterns and a higher
value for broader binding patterns. MACS does not require a control (commonly
DNA input) sample as a background. However, it is advisable to have a con-
trol for ChIP-seq as data obtained depends highly on sequencing depth, antibody
speciﬁcity, and variations of enrichment in the cell population. MACS also em-
pirically estimates the false discovery rate (FDR) if a control is provided. To this
end, MACS ﬁrst identiﬁes ChIP peaks relative to the control or background sig-
nal, and reverses this procedure by identifying peaks in the control, relative to the
observed data. The division of the number of control peaks by the number of ChIP
peaks provides an estimate of the empirical FDR. As a result, peaks are generated
in ChIP-seq data to identify signiﬁcantly interacting regions.
Other proteins mapped by ChIP-seq may reveal wide domains of enrichment,
such as nuclear lamins (Figure 10) [93]. Similarly, H3K9me3 and H3K27me3
also typically generate a diffuse enrichment pattern along the genome; of note,
we found that H2BS112GlcNAc also produces a diffuse enrichment pattern; see
Paper II. Due to low signal-to-noise ratio, it is not feasible to use traditional
peak callers like MACS to identify signiﬁcantly binding regions for broad binding
patterns. To determine binding domains, algorithms like Sicer [199], BroadPeak
[200], RSEG [201] and EDD [93] have been developed.
EDD, developed in our laboratory, provides a better overall match with en-
richment patterns for ChIP-seq data with large domains. This is because EDD is
highly robust against local variations and works with the size of the domains rather
than signal-strength. Binning the genome is a key ﬁrst step for EDD. Binning is
performed by dividing the length of the genome into equal sizes. For example, a
sequence of 100 kb can be divided into 10 bins of 10 kb. EDD divides the gen-
ome in bins of equal size and calculates the smallest bin size that would provide
the most information by estimating the signal in the bin using the Agresti-Coull
method [202]. The signal in the bins is displayed as the ratio of ChIP reads over
input reads where input is normalized by the ratio of sequencing depth difference
between the samples. Thus, noisy lamin A/C data (Figure 10, gray) is transformed
into a clear positive or negative signal (Figure 10, black) for each bin. EDD gen-
erates peaks by scoring consecutive bins where non-informative and depleted bins
20
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Figure 10: Different types of enrichment proﬁles generated by the mapping of ChIP-seq reads.
H3K4me1 produces narrow peaks and H3K36me3 produces wider peaks. These can be analyzed
using traditional peak callers. Lamin A/C has an extremely diffuse chromatin binding pattern.
Normalized data allows to view enrichments and depletions in the sample over background levels.
are assigned a gap penalty. Domains are detected by using a linear algorithm for
identifying maximal scoring subsequences [203] and ﬁnally assigning P-values
using Monte Carlo trials [204]. Thus, using EDD as a domain caller for ChIP-
seq data with diffuse binding patterns like lamin A/C, H2BS112GlcNAc provides
a solid base for downstream analyses for such data sets as shown by Lund et
al. [93].
1.5.3 Modeling of chromatin states
Segmentation of genomic data helps differentiate the genomic regions based
on their functionality. As mentioned earlier (section 1.1.1), regions of the genome
are deﬁned based on their functionality, such as promoters, enhancers, exons, etc.
and these regions have been found to house speciﬁc histone modiﬁcations. There
has been an exponential increase in the availability of epigenetic data in recent
years with the large scale sequencing projects carried out by consortia such as EN-
CODE Consortium [131], Epigenomics Roadmap [205], and Fantom [206]. Thus,
it has become increasingly common to study combinations of epigenetic marks.
These combinations may encode distinct biological functions [207]; however, the
functional signiﬁcance of combinations of epigenetic marks are mostly unknown.
Studying combinations of histone modiﬁcations in tandem by analyzing multiple
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data-sets with distinct sets of signals and peaks is difﬁcult to parse. Thus, in addi-
tion to aiding interpretation, studying various combinations of epigenetic modiﬁc-
ations based on their segmentation along the genome gives a deeper understand-
ing of the co-occurrence of chromatin marks on the genome. ChromaSig [208],
Segway [48] and ChromHMM [209] are the three main methods performing seg-
mentation based on epigenetic marks.
ChromaSig, released in 2008, works in two steps. First, it identiﬁes 2 kb loci
which are highly enriched in chromatin marks. In order to take chromatin signa-
tures in the vicinity into account, a 7 kb window around the enriched 2 kb loci is
searched to generate a signature motif pattern of 4 kb. A 4 kb length ensures that
the motif covers at least 75% of the enriched loci. Second, ChromaSig clusters,
aligns and orients the enriched loci identiﬁed in the ﬁrst step based on the Euc-
lidean distance between the chromatin modiﬁcations in the motifs. This method
was a breakthrough in genomic segmentation. However, unlike later algorithms,
ChromaSig does not perform genome-wide segmentation.
ChromHMM segments the genome using a multivariate Hidden Markov Model
(HMM) [209]. ChromHMM ﬁnds a local optimum of the parameter values using
a variant of the standard expectation-maximization based Baum-Welch algorithm.
In this case, the algorithm completes one iteration over the chromosomes for the
dataset, and applies an incremental expectation-maximization procedure so that
parameter estimates are incorporated rapidly. The algorithm, by default performs
200 iterations. However, it should be noted that often, with numerous data-sets,
the algorithm will not demonstrate convergence in 200 iterations and hence, more
iterations should be performed if required. The model can be explained as il-
lustrated in Figure 11. In this example (Figure 11A), there are three states (P =
promoter, G = gene body, B = blank) which can be identiﬁed using H3K4me3 and
H3K36me3. A state would, for example, be a promoter state if H3K4me3 has an
emission value of 1 and H3K36me3 has an emission value of 0. The transition
probabilities for going from one state to another are displayed by the arrows. A
promoter state has the highest transition probability (0.8) to a gene body and a
low transition probability to a promoter state (0.1) or a blank state (0.1) whereas
a blank state would have almost no chance (0.01) of transitioning to a gene body.
In the case of calling states using ChromHMM, the sequence of observations is
known (where the histone PTMs are located), and the sequence of states (P, G, B;
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see above) is unknown. Thus, using the forward-backward algorithm can provide
the posterior probability distribution for each hidden state interval, conditional on
the observed data. In order to identify states in the genomic sequence, the se-
quence can be divided into bins and the most likely hidden state, for each bin, can
be inferred based on the trained model. In Figure 11B, the sequence starts with
a B since there is no signal for either histone PTMs. The probability for the next
state, which is B, is provided by the forward-backward algorithm. The forward-
backward algorithm ﬁrst calculates the transition and emission probabilities in a
forward and backward pass. A smoothed value is generated by combining the two
probabilities. Thus, two states which are rarely observed consecutively, can still be
found next to each other using the forward-backward algorithm (Viterbi algorithm
can be used instead to identify the most probable sequence of states). In the ﬁrst
step, the algorithm computes a set of forward probabilities to end up in state B
given the observations in the previous states. In the second step, the algorithm
computes a set of backward probabilities which would determine the probability
of observing the remaining states given any starting state. Thus, the two prob-
abilities can be combined to obtain the distribution over any speciﬁc bin in the
sequence given the entire observation sequence. Continuing in the sequence, the
third bin has H3K4me3 and a low signal from H3K36me3. The transition prob-
abilities and emission probabilities, in this case, dictate the state transition to P. In
this manner, ChromHMM segments the genome using multivariate HMMs which
are graphical probabilistic models that model multiple ’observed’ inputs generated
by unobserved ’hidden’ states, using transitions between hidden states to model
spatial relationships [209].
The number of states to be modeled by ChromHMM is decided by the user.
Given a study with 7 tracks of histone modiﬁcation data, there is theoretically a
chance of ﬁnding 7! (factorial 7) combinations of present/absent signal for each
bin in the genome which would mean a total of 5040 possible states. However,
that would create too many states to analyze. Additionally, it would also make
more biological sense to only have a combination of certain genomic elements,
such as e.g. H3K4me1 with H3K27ac which mark enhancers. It is also import-
ant to clearly consider what the end-result of the state-calling should be. If the
user wants to easily interpret the data, few (and easily interpretable) states should
be chosen. So, it is important to try a varied number of state calls which would
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Figure 11: Illustration of HMM. (A) Three states (Promoter = P, Gene body = G, Blank = B) have
their own emission probabilities (red, green dotted arrows) and each state has a transition probab-
ility (black arrows) to move from one state to another. The emission and transition probabilities
dictate the state call together. (B) Generation of a chain of states based on the observations and
probabilities from the trained model.
explain the datasets concisely and precisely. The authors of ChromHMM [209]
used the Bayesian Information Criterion (BIC) to identify the optimal number of
states to be included in the model. BIC, in simple words, penalizes the inclusion
of extra model parameters that do not increase the likelihood accordingly. The
optimal number of states is therefore given by the model with the lowest possible
BIC score. The model generated can be pruned to eliminate states such that the
remaining states have the least distance from their closest emission vector in the
remaining states. For example, ChromHMM can be used to generate a 15 state
model using seven datasets as shown in Figure 12. For example, state 6 (dark
green) is marked by only H3K36me3, state 13 (yellow) is marked by a combina-
tion of H3K27ac, H3K4me2, H3K4me3 whereas state 7 (black) is devoid of the
marks being studied here. After the emissions for the 15 states have been gener-
ated, the user can annotate the states manually using prior knowledge on the func-
tions of the chromatin marks. Thus, identifying the optimum number of states is a
compromise between resolution and diversiﬁcation of the data, and is dependent
on the overall goal of the study.
Segway and ChromHMM are very similar in their ﬁnal output and method.
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Figure 12: ChromHMM segmentation. Epigenetic information is condensed to allow visualization
and further down-stream analyses on multiple epigenetic marks at a single location.
Segway uses a Dynamic Bayesian Network (DBN) to model the complex hidden
relationships which explain the observed data sampled at regular intervals of the
genome as an axis [48]. A DBN can represent a standard HMM through a random
variable for the hidden state of the HMM along with an observed random vari-
able for the observations. However, a DBN can incorporate complex relationships
among variables. A DBN models the interrelationship between multiple hidden
variables without the need to ﬂatten them into one variable. Segway simultan-
eously segments and clusters genomic data. The authors of Segway have shown
that this algorithm is capable of "rediscovering" annotated regions of the genome
using DNase-seq data, FAIRE-seq and ENCODE data by unsupervised training
of a portion of the human genome [48]. They also compared their ﬁndings with
ChromHMM and identiﬁed that Segway generated a ﬁner-grained segmentation in
comparison to the former. ChromHMM segmentation with the same dataset gen-
erated segments with a mean length of 4,862 bp and a median of 800 bp whereas
Segway had a mean length of 168 bp and a median of 124 bp. Thus, Segway has
a better ability to detect elements at a sub-nucleosomal resolution [48].
1.5.4 Hi-C analysis
Hi-C provides high resolution maps for genome-wide chromosomal interaction.
As with ChIP-seq, Hi-C analysis begins with mapping of sequencing data to a
reference genome. Hi-C always requires paired-end sequencing. Thus, mapping
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both mates of each paired sequence can result in (i) none of the mates in the pair
being uniquely mapped (ii) only one mate of the pair being uniquely mapped (iii)
both mates mapping to the same bin (iv) both the mates in a pair being mapped to
separate bins. In the ﬁrst case, the pair is discarded. In the second case, the mate
that mapped can be saved to be included in downstream analysis, for example,
avoiding artifacts resulting from excluding reads that have frequent interactions
with repeat regions from one end. The third case is caused due to the presence
of dangling-ends caused due to self-circularization or self-ligation and these reads
should be discarded. There is also a bias caused by PCR ampliﬁcation and all
reads that map at the same location multiple times should be removed [210]. All
reads from the fourth case should be saved for identifying signiﬁcant interactions
between chromatin segments [210].
In one of the ﬁrst studies to identify signiﬁcant Hi-C interactions, the au-
thors sought to infer interactions that were more frequent than the background
signal [211]. The authors treated the inter-chromosomal and intra-chromosomal
reads separately to identify signiﬁcant interactions in each set. A uniform probab-
ility model was assumed for interactions between pairs of restriction fragments.
The probability of observing any particular interaction was calculated as a ra-
tio of one divided by the total number of possible inter-chromosomal pairs of
the restriction fragments. The probability of observing a particular number of
inter-chromosomal interactions was given by the binomial distribution. However,
for intra-chromosomal interactions, the genomic distance had to be accounted for
since chromosomes act as polymers and have a higher probability for random
contacts with shorter genomic distance. This was corrected by the authors by
grouping the contacts in discrete 5 kb bins and the probability within each bin
was calculated separately. Thus, as noted by the authors, the probability of the
contacts is conditioned by the genomic distance.
The above method was reﬁned in a follow-up study which focused on identi-
fying signiﬁcant interactions at a genomic scale of ∼50 kb to 1 Mb [212]. The
authors modeled a combination of the random interaction due to genomic dis-
tance and other biases in Hi-C data. These biases include a non-uniform distri-
bution in restriction fragments in the genome due to different frequency of re-
striction sites in each bin. Biases also include GC-content, fragment length and
mappability [213]. The bias was incorporated by using an iterative correction and
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eigenvector decomposition model [210] in conjunction with a monotonic spline
ﬁtting procedure. The authors excluded bins with a very high or low bias when
generating P-values.
1.5.5 ChiA-PET analysis
ChiA-PET provides interaction maps within the genome, mediated by a selec-
ted protein of interest that has been immunoprecipitated. Mapping paired-end
ChiA-PET data results in two types of ligation products: self-ligations and inter-
ligations (see section 4.2). Since ChiA-PET does not map contacts for the entire
genome, it is required to ﬁrst identify the sites (anchors) where interactions occur.
For this, the inter-ligations can be used in a similar fashion as ChIP-seq data (see
section 1.5.2), to detect peaks (anchors) [120, 125]. Pairs with one mate mapping
to each of these two anchors are counted to identify the raw signal between each
pair. ChiaSig [214] can be used to identify signiﬁcant interactions between such
anchors across the genome. ChiaSig was the ﬁrst method that took the genomic
distance between the anchors into account, when inferring the signiﬁcance of the
interactions. ChiaSig extends the hypergeometric distribution used by previous
methods [120] and replaces it with the non-central hypergeometric distribution,
and has been proved to identify relevant signiﬁcant interactions and averting the
over-estimation of shorter interactions. Thus, by using deﬁned regions as an-
chors in conjunction with ChiaSig, it is possible to identify signiﬁcant interactions
between only regions associated by a given protein or histone PTM of interest.
1.5.6 Predicting chromatin interactions
Since generating Hi-C and ChiA-PET data-sets is expensive and exhaustive,
methods are being developed to predict interactions in the genome by modeling
known information instead of producing Hi-C datasets for each cell type. As op-
posed to the prediction of putative enhancers (by p300, H3K4me1, H3K27ac),
there is no consensus predictor of interaction between promoters and enhancers.
Several unsupervised and supervised methods have been proposed to identify in-
teracting P-E pairs.
One of the most basic unsupervised methods for predicting P-E interactions
is to simply select the nearest enhancer to the promoter [215,216]. However, only
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a fraction (∼40%) of enhancers interacts with the nearest promoter [215, 216].
Thus, selecting P-E pairs only in the same TAD has provided better results [119,
149]. One variant uses sequence co-conservation for the promoter-enhancer pair
[217,218]. Another approach is to select promoters within a certain distance from
each enhancer and identify interactions based on activity correlations for DNase
I hypersensitivity sites [219]. The authors also corroborate the ﬁndings with 5C
and discovered that roughly only half of the predicted promoter-enhancer pairs
were markedly enriched in long-range interactions but not necessarily signiﬁcant.
Ernst et al. developed a method that uses correlation between promoter and en-
hancer states in conjunction with genomic distance (minimum distance of 5 kb;
maximum distance of 125 kb). This method incorporates both genomic distance
and correlation values in a logistic regression classiﬁer to identify ’real’ P-E inter-
actions [47].
Recently, PreSTIGE was developed to identify cell-type speciﬁc P-E inter-
actions [220]. PreSTIGE ﬁrst identiﬁes enhancers deﬁned by H3K4me1 and
provides speciﬁcity scores based on Shanon’s entropy [221], and cell-type spe-
ciﬁc enhancers are considered active. The step involves pairing the enhancer to a
promoter which is closer to the enhancer site than the closest CTCF site, or 100 kb
at the farthest. Considering the complications and chromatin marks required for
predicting P-E interactions, it is imperative to use more features and non-linear
models for predicting P-E interactions.
Supervised methods have been developed to predict P-E interactions. Ran-
dom Forest (RF) classiﬁcation is a popular method employed for this purpose. It
is better to use tree-based methods as opposed to linear regression methods since
there is not always a linear function that can explain the relationship between ge-
nomic datasets [222]. IM-PET is an example of an algorithm developed to use RF
to predict P-E interactions [216]. On average, 36,823 P-E interactions from 12
cell-types were identiﬁed. The authors used promoter activity level, TF binding
probability based on binding motif, sequence and synteny conservation informa-
tion, and distance between promoters and enhancers as the features for generating
the RF model. Another algorithm, RIPPLE, also employs RF to identify P-E inter-
actions [222]. The authors selected the set of features that worked best across four
cell types which were CTCF, cohesin (RAD21), H3K4me2, H2K27ac, H3K9ac,
H3K36me3, H4K20me1, H3K27me3, DNase I, and TBP (a TF). The authors
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cross-checked the predicted genome-wide maps using Hi-C data and identiﬁed
that high conﬁdence interactions (in the 90% percentile) had signiﬁcantly more
contact counts in the Hi-C than low conﬁdence intervals (in 10% percentile). This
corroborates the prowess of RF in predicting genomic interactions.
RF is a tree-based method which creates multiple trees from many random
subsets of the data and tests the robustness of the model on another subset of
the data, thus providing information on the importance of each of the features in
the dataset and error rate of prediction using those features. The process of a tree
generation is illustrated in Figure 13. For example, the full set consists of P-E pairs
with two possible outcomes (i) signiﬁcant interactions and (ii) non-interactions.
Each pair, regardless of the outcome, is quantiﬁed by a set of features as shown
by the shapes. A tree is built by taking a random subset from the full set of
observations and dividing it into a training set (2/3 of the subsample) and a test set
(1/3 of the subsample, known as “Out-of-Bag” (OOB)). Simultaneously, a random
subset is generated from the list of describing features as well. The features act as
the nodes of the tree. The outcomes in the training set are split based on the best
classiﬁer from the ﬁrst set of random features and the remaining outcomes are
subsequently split using another feature from another random set of features and
so on until the terminal nodes (leaves) of the tree contain outcomes of only one
value. Once a tree is generated from the training set, the P-E pairs from the test set
traverse down the tree based on the values of their features, and their outcome is
predicted and subsequently compared with its known outcome. The percentage of
false predictions provides the OOB error rate. This process of training and testing
is iterated multiple times leading to the formation of a forest and an overall OOB
error rate. Eventually, through the randomization process, each pair will have
both helped construct a tree and test a tree. Once a model has been generated, the
RF can predict the outcome for P-E pairs with unknown outcomes (unknown set).
These pairs will however need to have a value for the features used to develop the
RF. Each P-E pair from the unknown set will traverse down all the trees generated
in the model. The predicted outcome for each P-E pair from each tree is counted
as a vote. The ratio of the votes determines the outcome of the P-E pair. For
example, if for one P-E pair, there are 300 votes for signiﬁcant interaction and
100 votes for no interaction. Then the outcome is signiﬁcant interaction for the
P-E pair with a classiﬁcation probability of 0.75. Thus, random forests can be
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Figure 13: Random forest generation. Random samples are taken from the full set of known data
to generate a random forest model and test it on a subset to quantify the accuracy of the model.
used to predict the outcome of results based on features that are relevant to the
outcomes in a robust way by generating results from thousands of permutations.
1.5.7 RNA-seq analysis
RNA-seq is an HTS-based tool for estimating the relative abundance of tran-
scripts in a cell or a population of cells. Expression levels in RNA-seq are typ-
ically measured in either reads per kb per million base pairs mapped (RPKM),
or fragments per kilobase per million base pairs mapped (FPKM) [173]. RPKM
is calculated for single end RNA-seq as there is only one read that provides in-
formation about the transcript. FPKM is calculated for paired-end RNA-seq when
two mates of a pair provide information about the sequenced transcript as in this
case reads are obtained from both ends of one fragment. FPKM is calculated by
counting the number of reads mapping to a gene and then dividing that count by
the length of the transcript in kb. Expression levels are normalized by dividing
them by the total sequencing depth in Mb. This scales the expression levels of
genes irrespective of sequencing depth. For example, FPKM of a transcript that
is 10 kb in length with 1000 fragments mapping on the transcript at a sequencing
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depth of 50 Mb would be calculated as follows:
FPK (Fragments Per kb (of transcript)) = 1000 / 10 = 100
FPKM (FPK per Million (of mapped fragments)) = 100 / 50 = 2
There are four major steps typically used for analyzing RNA-seq data.
(i) Mapping of data to a reference genome. Genome alignment from ChIP-
seq data depend on the BWT and FM index for rapid alignment. However, such
methods are not optimal for mapping RNA-seq data, since the data stem from
RNA transcripts instead of genomic DNA. Due to splicing, RNA editing, and
the presence of multiple RNA isoforms, mapping the data back to the genomic se-
quence is not trivial. This process can be complicated by incomplete knowledge of
the reference genome (and transcriptome) and aberrant splicing events in mutated
cells [223]. Thus, a mapping algorithm for RNA-seq should be able to align reads
across splice junctions and handle paired-end reads from long-range splices in a
reasonable time-frame. TopHat2 is one of the most popular RNA-seq mapping
algorithms which satisfy these criteria [224]. TopHat2 ﬁrst maps all reads to a
transcriptome with known junctions. The reads that do not map are then mapped
to the reference genome to identify unannotated exons. This step creates two lists.
One with reads spanning a single unannotated exon which are mapped and multi-
exon spanning reads which are unmapped. The unmapped reads are then split
into smaller segments which are realigned to the reference genome and reads for
which both the left and right segments are mapped, the most likely splice junctions
are identiﬁed. Further, to align reads that do not map in the previous step, ﬂanks
of exons are concatenated to form a new transcriptome and unmapped reads are
aligned again. Finally, TopHat2 realigns multi-mapped reads based on the new
transcriptome and splice junctions, and reports only the most likely locations for
the mapped reads. Thus, TopHat2 manages to map as many reads as possible from
the sequenced sample ensuring minimal loss of information.
(ii) Transcriptome reconstruction and quantiﬁcation. Mapping the data
only informs the location of the sequences in the reference genome. These se-
quences need to be allocated to their respective known transcripts to estimate
the abundance of various transcripts of a gene while simultaneously estimating
alternative isoforms which is performed by algorithms such as Cufﬂinks [225].
Cufﬂinks ﬁrst identiﬁes ’incompatible’ fragment pairs which most likely origin-
ate from distinct spliced isoforms. An overlap graph is generated by connecting
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’compatible’ fragments that overlap in the genome with each fragment having a
node in the graph. For example (Figure 14A), the red, blue and yellow fragments
might be separate isoforms and the black fragments could originate from either
of the three isoforms as one end in each of these fragments does not overlap an-
other fragment in the sample. The minimal path covering the mutually compatible
fragments for the three isoforms is shown in Figure 14B. This is in concordance
with Dilworth’s theorem [226] where (in RNA-seq context) all fragments can be
explained when the number of isoforms is equal to the number of mutually incom-
patible fragments. The previous steps are done in small bundles to be computa-
tionally fast and efﬁcient. The results are then concatenated to identify abundance
for each of the transcripts. This is done by matching fragments to the possible
transcripts. For example (Figure 14C), the black fragments can be part of all three
isoforms whereas the violet fragment can be in either the red or the blue isoform.
It can only be assigned to one isoform as assigning to multiple isoforms would
imply different cDNA lengths for the same fragment. It would be improbable for
the violet fragment to originate from the red isoform due to its larger length. Thus,
it would be assigned to the blue isoform. In order to conﬁrm this, Cufﬂinks as-
signs the maximum-likelihood abundance to each isoform which can best explain
the mapped fragments as illustrated in the pie chart (Figure 14D).
(iii) Differential gene expression analysis. Identifying differentially expressed
genes is not a necessary step for analyzing RNA-seq data and is only necessary
to compare the expression levels between two or more treatments or differen-
tiation stages of cells. Algorithms used for identifying differentially expressed
genes between data sets have been scrutinized using simulated [227] and real
data [228] to assess their efﬁciency and accuracy to produce a list of differen-
tially expressed genes. Data from RNA-seq experiments generate a skewed dis-
tribution with the majority of the genes having expression at the lower end of
the scale and thus making it difﬁcult to use parametric methods to identify sig-
niﬁcantly differentially expressed genes from raw counts. Methods developed
for this purpose are mainly based on negative binomial models (edgeR [229],
DEseq [230]), non-parametric approaches (SAMseq [231]), and transcript-based
methods (Cuffdiff2 [232]). edgeR uses an empirical Bayes procedure to moder-
ate over-dispersion across genes by borrowing information from other genes. The
data among samples is normalized using a Trimmed mean of M values method
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Figure 14: Overview of Cufﬂinks. (A) Possible isoforms are identiﬁed from the mapped fragments
based on overlap. (B) A graph is generated and transcripts identiﬁed based on the shortest path.
(C) Abundance for each transcript is measured based on the most likely transcript a fragment
originated from. (D) Transcripts are quantiﬁed by the maximum-likelihood abundance. Figure
adapted from [225]
[233]. It uses an exact test adapted from Fisher’s exact test to incorporate over-
dispersed data and uses Benjamini-Hochberg method [234] to generate FDR val-
ues. SAMSeq uses the non-parametric Wilcox rank test in conjunction with a
resampling procedure (accounts for variable sequencing depth) followed by a
permutation-based method to generate FDR values. Cuffdiff2 uses a beta neg-
ative binomial model for fragment counts. This controls variability and ambigu-
ous read mapping as it estimates expression at a higher resolution of transcript
level. The resolution of Cuffdiff2 also enables it to provide differential expres-
sion at promoter, isoform and gene levels. It normalizes data to the sequencing
depth and uses Benjamini-Hochberg method to generate FDR values. There are
pros and cons for each method as identiﬁed by different comparative studies and
the consensus remains divided [227, 228, 235]. Statistical tests based on negative
binomial methods provide the highest number of differential genes whereas tran-
script based methods tend to identify the fewest. Thus, multiple methods must be
tested before selecting an algorithm to identify differentially expressed genes.
(iv) Plotting and subsequent downstream analysis. This is the least de-
veloped step for RNA-seq analysis for in-depth cross data analysis. Most of the
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packages for RNA-seq analysis do produce plots for basic analysis. The Tuxedo
protocol [236] has provided a dedicated bioconductor [237] package to generate
plots, albeit, only for data generated from Cuffdiff. However, plots can also easily
be generated by using other packages in R [238,239] like ggplot2 [240]. Another
important way of showing RNA-seq (and/or ChIP-seq, and/or Hi-C) data is with
the use of genomic browsers such as Integrative Genomics Viewer (IGV) [241].
Loading data from RNA-seq analysis into IGV allows visualizing the difference in
expression levels of genes between genes and/or loci along the genome. One can
also add TF and histone PTM ChIP-seq data to obtain a graphical representation
of the chromatin environment of a given gene expression output (see Papers I and
II). Other downstream analyses can be performed based on transcriptomic data,
such as Gene Ontotology (GO analysis), Principal Component Analysis (PCA),
clustering based on expression values as we have done in Paper I.
1.6 Summary
The advent of high-throughput sequencing technology has led to the production
of a wealth of data which have given totally new insights into our understand-
ing of genome function. However, there is a huge gap in the knowledge of how
epigenetic modiﬁcations, protein-DNA interactions and interactions between ge-
nomic elements, e.g. between an enhancer and its cognate promoter, transition in
the course of development and cell differentiation to lead to the multitude of cell
types that make up an organism. In the doctoral work presented here, we have
largely relied on the differentiation of human adipose tissue stromal cells (ASCs)
into adipocytes [242] to unveil temporal changes in gene expression and associ-
ated chromatin modiﬁcations. This adipogenic differentiation system has been
established earlier in our laboratory [243] and is described in Paper I.
We then substantially establish that adipogenic differentiation is associated
with massive spatial reorganization of lamin A/C across the genome, through
dynamic changes in interactions of chromatin with nuclear lamins. We further
identify an epigenetic pre-patterning of de novo nuclear lamin-chromatin interac-
tions in this process, involving genomic domains of GlcNAcylated histone H2B
(Paper II). Finally, we propose a method to study interactions between pro-
moters and enhancers where genome-wide interaction data are unavailable, and
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predict promoter-enhancer interactions taking place during adipogenic differenti-
ation (Paper III).
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Chapter 2
Aims of the study
Chromatin remodeling is critical for the correct programing of developmental
gene expression. Recent work has provided a dynamic view of post-translational
histone modiﬁcations during cell differentiation; however there has been little in-
sight on the evolution of combinatorial genome-wide patterns of chromatin marks,
excluding an essential aspect of developmental gene regulation. Similarly, very
few studies have addressed the nature of global changes in chromatin organiza-
tion during differentiation. Using an in vitro adipogenic differentiation model,
this thesis addresses relationships between chromatin organization and develop-
mental gene expression patterns.
The aims of this study were therefore to:
• Identify chromatin states and their temporal relationship to gene expression
patterns during differentiation of human adipose tissue stem cells
• Determine whether adipogenic induction affects the genome-wide distribu-
tion of the nutrient-responsive S112GlcNAc modiﬁcation on histone H2B,
and bioinformatically characterize H2BS112GlcNAc domains (GADs)
• Map changes in the genome-wide association of chromatin with nuclear
lamin A/C during adipogenic differentiation, and characterize these associ-
ations
• Assess the relationship between changes in lamin A/C-chromatin interac-
tions and GADs driven by adipogenic differentiation, and their relationship
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to gene expression
• Develop a predictive modeling technique to infer signiﬁcant and dynamic
promoter-enhancer interactions in differentiating adipose tissue stem cells,
for which no chromosomal interaction data are available
Collectively, this work provides signiﬁcant insights on our understanding of
spatial genome organization in a dynamic differentiation context. It also provides
a new approach to inferring physical interactions between gene regulatory ele-
ments.
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Chapter 3
Summary of publications
3.1 Paper I: A hyper-dynamic nature of bivalent pro-
moter states underlies coordinated developmental
gene expression modules
(Shah et al., 2015 BMC Genomics 15, 1186)
Chromatin remodeling is crucial for proper programing of developmental gene
expression. Recent work provides a dynamic view of post-translational histone
modiﬁcations during differentiation; however there is little insight on the evol-
ution of combinatorial genome-wide patterns of chromatin marks, excluding an
essential aspect of developmental gene regulation. We report here a 15-chromatin
state Hidden Markov Model which describes changes in chromatin signatures in
relation to transcription proﬁles during differentiation of human pre-adipocytes
into adipocytes. We identify nineteen modules of gene expression reﬂecting mul-
tiple waves of transcriptional up- and down-regulation which characterize adipo-
genic differentiation. From our model, we developed chromatin state matrices ﬁt-
ting each of these transcription modules to show how the complexity and dynamic
nature of chromatin signatures relate to expression patterns. Spatial relationships
between chromatin states underlie a high-order chromatin organization in differ-
entiating adipocytes. We show the importance of gene expression level in generat-
ing diversity in chromatin signatures, and show that the hyper-dynamic nature of
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H3K4me2/H3K27me3-marked ‘bivalent’ promoter states underlies many of the
gene expression patterns associated with adipogenic differentiation. Our results
reveal the highly dynamic nature of bivalent promoter states within the adipo-
genic lineage. The data constitute a valuable resource enabling the assessment of
possibilities to alter the adipogenic program.
3.2 Paper II: Pre-patterning of differentiation-driven
nuclear lamin A/C-interacting chromatin domains
by GlcNAcylated H2B
(Rønningen, Shah et al. Genome Res., accepted)
Dynamic interactions of nuclear lamins with chromatin through lamin-associated
domains (LADs) contribute to the spatial organization of the genome. We provide
here evidence for a pre-patterning of differentiation-driven formation of lamin
A/C LADs by domains of histone H2B modiﬁed on S112 by the nutrient sensor
O-linked N-acetylglucosamine (H2BS112GlcNAc), which we term GADs. We
reveal a two-step process of lamin A/C LAD formation during in vitro adipogen-
esis, involving spreading of lamin A/C-chromatin interactions in the transition
from progenitor cell proliferation to cell cycle arrest, and genome-scale redistri-
bution of these interactions through a process of LAD exchange within hours of
adipogenic induction. Lamin A/C LADs are found both in active and repress-
ive chromatin contexts that can be inﬂuenced by differentiation status. We show
that de novo formation of adipogenic lamin A/C LADs non-randomly occurs
on GADs, which consist of megabase-size intergenic and repressive chromatin
domains. Accordingly, whereas pre-differentiation lamin A/C LADs are gene-
rich, post-differentiation LADs harbor repressive features reminiscent of lamin B1
LADs identiﬁed in other cell types. We ﬁnd that release of lamin A/C from genes
directly involved in glycolysis concurs with their transcriptional upregulation after
adipogenic induction, and with downstream elevations in H2BS112GlcNAc levels
and O-GlcNAc cycling. Our results reveal an epigenetic pre-patterning of adipo-
genic LADs by GADs, suggesting a coupling of developmentally regulated lamin
A/C-genome interactions to a metabolically-sensitive histone modiﬁcation.
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3.3 Paper III: Inference of promoter-enhancer con-
tacts from epigenomics datasets reveals dynamic
interaction during adipogenic differentiation
(Shah et al., manuscript)
Spatial genome conformation is central to the regulation of gene expression. In
mammalian genomes, chromatin looping events lead to interactions between pro-
moter and cognate distal enhancers to regulate transcription. Promoter-enhancer
(P-E) interactions can be identiﬁed genome-wide by high-throughput chromo-
some conformation capture techniques such as Hi-C and ChIA-PET. We report a
predictive modeling technique to infer signiﬁcant P-E interactions in cell types for
which such data are not available. Our methodology relies on training a random
forest model from Hi-C and genome-wide epigenomics datasets to predict signi-
ﬁcant P-E interactions and epigenetic features contributing to these interactions.
Accuracy of the predictive value of the model can be modulated by ﬁne-tuning
the selection of chromatin features. Our model points to constitutive CTCF bind-
ing across many cell types and DNase accessibility as the strongest predictors of
signiﬁcant P-E interactions. Applying our model to infer P-E interactions during
differentiation of adipose tissue stem cells identiﬁes dynamic developmentally-
linked P-E interactions compatible with the adipogenic transcriptional program.
Reliably predicting P-E interactions constitute a valuable tool to investigate the
developmental dynamics of genome architecture.
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Chapter 4
Discussion
4.1 ChromHMM application to genome-wide data
HTS technology has made multiple datasets available for genome-wide pro-
ﬁling of histone PTMs and chromatin-binding proteins. Genome segmentation
methods to identify co-occurrence of chromatin marks have therefore become in-
creasingly popular. These include Segway [48], ChromHMM [209] and Chro-
maSig [208].
In our work, we have used ChromHMM to segment the genome based on en-
richment proﬁles of seven chromatin marks including 6 histone PTMs (H3K4me1/2/3,
H3K27ac/me3, H3K36me3) and CTCF binding. We have not used ChromaSig
because it does not provide genome-wide segmentation [208] and therefore was
inadequate given the genome-scale nature of our analyses. Segway uses a DBN.
Thus, Segway is similar to ChromHMM since a standard HMM can be represen-
ted by a DBN. In comparison to ChromHMM however, Segway enables ﬁner gen-
ome segmentation without binning the data and handles missing data better [48].
The ability of a DBN to handle missing data is an advantage when the study uses
large numbers of epigenetic marks and there is missing data for different datasets.
However here, we used data consistent for each adipogenic differentiation time
points; thus the question of handling missing data did not arise and we chose not
to use Segway. Moreover, we used in our chromatin state analyses relatively few
chromatin marks (7); thus generating chromatin states at a ﬁner resolution (e.g.
with Segway) would result in excessive segmentation. We opted for a 15 chro-
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matin state HMM with a 200 bp fragmentation (Paper I, II, III); this provided a
robust base to relate with high conﬁdence epigenetic data to lamin A/C binding
and H2BGlcNAc enrichment patterns, whose detection required with the larger (1
kb) bins (Paper II, section 1.5.2). Thus, information at a sub-nucleosomal level
generated by Segway would be noisier and overwhelming in comparison.
Segway generates chromatin states based on a single base-pair resolution as
opposed to the binning approach of ChromHMM. Binning size in ChromHMM
can be adjusted to below 200 bp [47,209] to provide deeper resolution. However,
ChIP-seq read length is usually at least 50 bp, and chromatin fragmentation for
ChIP results in fragments of 200-500 bp, so resolution beyond that size at the
genome-scale level is in reality not possible. Thus, the molecular methods do not
provide location of the epigenetic mark(s) at base-pair resolution. Instead, aggreg-
ation of sequencing reads in a bin provides the most likely location of epigenetic
mark(s) in a genomic region. Thus, using 200 bp bins (approximately the size of
a nucleosome) in our study seemed most appropriate to identify binding regions
for the epigenetic marks considered.
Another difference between Segway and ChromHMM is that Segway uses an
inverse hyperbolic sine function to transform the signal values, whereas Chrom-
HMM uses a binary approach to identify the presence or absence of an epigenetic
mark in the bin. In fact, another algorithm based on HMM, EpiCSeg [244], also
works on signal values for the epigenetic marks. However, EpiCSeg does not take
into account the fact that most epigenetic modiﬁcations have different binding pat-
terns. For instance, H3K4me3 has a narrow binding pattern whereas H3K36me3
displays broader domains of enrichment. Lamin A/C and H2BGlcNAc have dif-
fuse binding patterns (Paper II). This results in varying numbers of signal in-
tensities for each of the epigenetic marks examined, leading to a high probability
of false state calls solely due to the lower enrichment level of one of the marks.
Through a binary approach, ChromHMM identiﬁes the cut-off for each mark in-
dependently using a Poisson distribution, and provides present/absent calls for
each mark for each bin. Thus, when using epigenetic data from different sources,
it is important to distinguish advantages and disadvantages of signals generated
from the marks; this task is performed well by ChromHMM.
Another key difference between Segway and ChromHMM is that Segway
uses the Viterbi algorithm to call states whereas ChromHMM uses the forward-
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backward algorithm. The advantage of the Viterbi algorithm is that it can identify
the probability of a sequence of states. Thus, states with a rare probability of
occurring one after another in the genomic sequence cannot be called; in Chrom-
HMM however, if emission and transition parameters are “right” for a given state,
the state can be called. This may be a drawback of ChromHMM; however in prac-
tice this matters little because the exact sequence of epigenetic marks along the
genome is largely unknown since a large number of epigenetic marks have still
not been proﬁled. Thus, despite the possibility to identify rare state sequences, it
was not a hindrance to use ChromHMM for segmentation in our study. In sum-
mary, it is clear that DBN presents advantages over an HMM, which might be
advantageous in settings outside biology. However, in our study, we rationalized
that ChromHMM was beneﬁcial over Segway to call chromatin states because it
suits the data at hand more appropriately.
4.2 Training a P-E interaction model can be inﬂu-
enced by features chosen
RF is a machine learning method that builds a model based on training data by
constructing a multitude of decision trees. In Paper III, we used histone PTMs
(H3K4me1/2/3, H3K27ac/me3, H3K36me3), CTCF and DNase I hypersensitivity
datasets to train a model from six cell types (GM12878, HMEC, HUVEC, IMR90,
K562, NHEK); we then used the model to predict P-E interactions in ASCs at four
stages of adipogenic differentiation, for which P-E interactions are not known.
Importantly, Random Forest can rank the importance of the features fed into the
model and returns their prediction power for a P-E interaction.
RF models have previously been applied to predict P-E interactions [216].
However, CTCF was not a model feature in that study. In Paper III, we show
that CTCF has in fact the highest predictive power for P-E interactions. This has
also been corroborated by ﬁndings that CTCF (together with the cohesin subunit
Rad21) contributes heavily to determine cell type-speciﬁc P-E interactions [222].
However, these authors do not differentiate between cell type-speciﬁc CTCF and
constitutive CTCF binding. We used three instances of CTCF binding in our
studies: CTCF counts at enhancer sites, cell type-speciﬁc CTCF counts and con-
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stitutive CTCF counts between a P-E pair. We concluded that constitutive, rather
than cell type-speciﬁc CTCF binding, is the strongest predictor of P-E interac-
tions.
Recently, the role of CTCF binding motif orientation in the formation of TADs
has been reported [143, 167, 245]. Interestingly, inversion of orientation of CTCF
binding motifs using CRISPR/Cas9 genome editing leads to reconﬁguration of the
topological domain between an enhancer and its cognate promoter, resulting in a
change in gene expression [246]. Adding direction of the CTCF binding motif as
a feature for identiﬁcation of P-E interactions would provide a stronger predicting
power for P-E interactions than merely CTCF binding in our model. This remains
to be tested.
Distance between an enhancer and its cognate promoter has previously been
used to model P-E interactions [216]. It is also most common to use the closest
promoter as the target of an enhancer [215]. However, there is a higher probab-
ility of ﬁnding a random interaction with shorter distance when using ChIA-PET
or Hi-C data since chromosomes act as polymers [214]. Thus, inclusion of gen-
omic distance can introduce a bias by learning subtle but artifactual differences in
genomic distances between the true interactions and the computationally sampled
non-interactions. Thus, we selected non-interacting P-E pairs with genomic dis-
tance as close as possible to the corresponding true interactions (Paper III) in-
stead of adding genomic distance as a feature.
Sequence co-conservation has also been used as a feature to model P-E inter-
actions [216]. The principle is that if an enhancer has to interact with a cognate
promoter, there is an evolutionary incentive to prevent a loss of interaction capab-
ility. Studies suggest a higher probability for P-E interactions to be in a conserved
synteny block [217, 218, 247]. Thus, rather than using genomic distance as a fea-
ture, positioning of a P-E pair in a synteny block could be used as a softer distance
constraint.
TADs are conserved across cell-types [248] and could also be used as a fea-
ture in modeling P-E interactions. Indeed, interacting P-E pairs appear in the same
TAD [249]. However, a reliance of TAD formation on CTCF-binding site direc-
tion has recently been shown [246]. Using CRISPR/Cas9-based genome editing
in conjunction with 4C and Hi-C, a reversed orientation of CTCF-binding sites at
protocadherin (Pcdh) and β-globin loci has been achieved, resulting in reorienta-
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tion of TADs and in turn the loops between the enhancer and the gene loci; alter-
ing gene expression patterns [246]. Although this was not shown genome-wide,
it appears that interaction of enhancers harboring CTCF sites with their cognate
promoter can be determined by the underlying genomic sequence. Thus, using
both CTCF binding direction and TADs may be redundant in the training model.
On the other hand, TADs could be used as a soft distance parameter instead of or
in combination with a conserved synteny block.
Gene expression levels have not been included as a feature of our RF model.
This is a drawback since a P-E interaction increases promoter strength and cog-
nate gene expression level. Since H3K27ac marks active enhancers, a correla-
tion value between expression level and H3K27ac levels on the enhancer would
provide a differentiating value between interacting and non-interacting P-E pairs.
Thus, adding correlation between expression and enhancer H3K27ac levels would
potentially increase the predictive power and accuracy of the model.
Enhancers were initially identiﬁed by ﬁnding regions of the DNA with a high
density for TF binding sites [250]. Thus, ChIP-seq is increasingly being used to
identify regions bound to TFs in order to locate context speciﬁc enhancers [118,
251,252]. P300 and CBP binding sites have been used to identify enhancers [253–
255]. However, they may not be as informative as the combination of H3K4me1/2
and H3K27ac (used in Paper III) because P300 and CBP are found only on a
subset of active enhancers [47, 49, 117, 122, 255]. We have therefore not used
these features for enhancer identiﬁcation (Paper III).
RNAPII at enhancers transcribes short enhancer RNA (eRNA) bi-directionally
[256]; conﬁrmed with bi-directional transcription from FANTOM5 TSS data [206,
215]. eRNAs have been used to measure activity of enhancers identiﬁed by
H3K4me1 and showed positive correlation with expression levels of nearby genes
[256]. eRNA maturation directly inﬂuences P-E interactions [257]. eRNA iden-
tiﬁcation emerges as an accurate method of identifying active enhancers; how-
ever, the function of eRNA remains unexplored. It is also unknown if eRNAs
are produced by all active enhancers, and eRNAs may also be cell type-speciﬁc,
leaving quantiﬁcation of P-E interactions using eRNAs context-dependent. Thus,
even though H3K27ac does not always provide a strong correlation with enhan-
cer activity [49, 117], it remains, together with H3K4me1/2, a robust alternative
as a marker of enhancer activity. Prediction of enhancers and P-E interactions is
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still in its infancy and will require more investigations to provide “true” positions
of constitutive and cell type-speciﬁc enhancers. Predicted interacting P-E pairs
identiﬁed in Paper III should therefore be considered as putative interactions.
4.3 Where does multivalency of chromatin states ap-
pear from?
We report that the enhancer mark H3K4me1 is retained during differentiation;
however the H3K4me1/H3K27ac combination is more dynamic (Paper I), in line
with studies showing cell type-speciﬁcity of H3K27ac [258, 259]. H3K4me1
marks enhancers which might be active or in a poised state whereas H3K27ac
marks active enhancers. Thus during differentiation H3K27ac levels would be
expected to vary based on the activity of the cognate gene [27]. We show that
adipogenesis involves activation of genes in cohorts (Paper I); thus a reason to
maintain H3K4me1 on enhancers may be to keep them “poised” to interact with a
cognate promoter and modulate lineage-speciﬁc gene expression as differentiation
proceeds.
The ﬁnding that the combination of H3K4me2 and H3K27me3 is the most
dynamic during differentiation is striking (Paper I). This may be attributed to
H3K27me3 per se: indeed we also identify an “H3K27me3-only” state as highly
dynamic, while other states containing H3K4me2 are more stable. Adipogenic
induction involves removal of H3K27me3 [260]. H3K4me2 and H3K27me3 co-
incidence on adipogenic genes may represent an epigenetic “poising” for later
transcriptional activation [260].
It should also be noted that our work relies on a cell population rather than
single cells. Thus, it is unknown whether both marks occur on the same locus or
whether they represent two distinct epigenetic marking (H3K4me2 or H3K27me3)
in two cell sub-populations. Multivalency of histone PTMs can be tested by per-
forming a sequential ChIP [260]; it would be informative to extend single-gene se-
quential ChIP analyses to a genome-wide mapping of co-incidence of H3K4me2
and H3K27me3 in an adipogenic context to provide information on multivalency.
48
4.4 The genic content of H2BGlcNAc domains (GADs):
resolving the discrepancy
The difference reported in the genomic enrichment of H2BS112GlcNAc in Pa-
per II and in a previous report [18] is in the genic content. We have shown that in
ASCs and adipocytes, H2BGlcNAc localizes primarily in intergenic regions and
that genes found in GADs are repressed (Paper II). In contrast, Fujiki et al. report,
in HeLa cells, H2BGlcNAc mainly in genes that are transcriptionally active [18].
Several factors may explain this discrepancy.
One is the anti-H2BGlcNAc antibody used. Whereas Fujiki et al. [18] used a
custom-made rabbit polyclonal antibody, we used the only H2BGlcNAc antibody
available – a polyclonal antibody from Abcam raised against a 12 amino acid
peptide of H2B GlcNAcylated on S112. We were not able to access the Fujiki
antibody during our work. Thus, we have extensively characterized the Abcam
antibody (Paper II) to conclude that the Abcam antibody is not entirely speciﬁc
for S112GlcNAc as it appears to cross-react with an unmodiﬁed H2B peptide
sequence. However, it is speciﬁc enough to ensure robustness of our ChIP data. It
would be interesting to assess H2BGlcNAC proﬁles using the Fujiki antibody in
ASCs, but this seems currently out of reach.
A second factor is the cell types examined. While Fujiki et al. [18] proﬁled
H2BGlcNAc in HeLa cells (a polyploid cell line) we examined primary normal
diploid cells [261] which could display a different GAD pattern. To address the
issue of cell type-speciﬁcity of GADs, we have mapped by ChIP-seq using the
Abcam antibody in HepG2 hepatoblasts lamin A/C LADs and H2BGlcNAc. To
determine how dynamic lamin A/C LADs may be in relation to GADs, HepG2
cells were also treated with cyclosporin A (CspA) to induce an adipogenic pheno-
type. Using EDD, we show a redistribution of lamin A/C LADs after stimulation,
and a change in the genomic properties of these LADs (namely, an increase in
gene density; Figure 15A,B). Changes in LAD patterns are manifested by loss of
LADs, gain of LADs or extension of existing LADs (Figure 15C). Thus, as in
ASCs, lamin A/C LADs are remodeled during adipogenic stimulation of HepG2
cells; however in this system lamin A/C LADs tend to become surprisingly gene-
rich after stimulation.
Next, a GAD overlap analysis (Figure 15A,D, column 2) indicates that GADs
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Figure 15: Characteristics of LADs and GADs in control and CspA-stimulated HepG2 cells. (A)
Percent of the human genome covered by LADs and GADs. (B) Gene density in LADs and GADs.
(C) IGV browser view of LMNA and H2BGlcNAc enrichment in a region of chromosomes 1 and
7 in control (Ctl) and CspA-stimulated HepG2 cells. Red frame highlights a region of de novo
lamin A/C enrichment in CspA-treated cells, in an H2BGlcNAc-rich domain. (D) Jaccard index
determination of the overlap between LADs and GADs in HepG2 cells before (Ctl) and after CspA
treatment. Note the increase in lamin A/C (LMNA)-H2BGlcNAc overlap after CspA treatment
(red arrow). A. Sørensen and P. Collas, unpublished.
are maintained between control and CspA-treated cells. Strikingly however, GAD
gene density is higher from that of ASCs. Since we used the same antibody in both
studies, this suggests that the genomic context of H2BGlcNAc varies between
cell types and may represent a difference between primary cells and cell lines.
The latter is supported by enrichment of H2BGlcNac in genes in HeLa cells [18];
however, more work is needed to validate this possibility, notably by ChIPing
H2BGlcNAc from HeLa cells.
We further show in Paper II that during ASC differentiation, lamin A/C LADs
form almost exclusively on GADs, suggesting that GADs pre-pattern de novo
LAD formation. Our data from HepG2 cells show that a large proportion of de
novo lamin A/C LADs form on GADs (Figure 15C,D). This suggests that as in
ASCs, de novo lamin A/C LADs in HepG2 cells may be pre-patterned by GADs.
We are currently testing whether this hypothesis is correct by altering GAD posi-
tion and determining whether this affects lamin A/C LAD patterns.
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4.5 Genome architecture, epigenetic marking and
gene expression are regulators of cell fate: work-
ing models and future perspectives
In this thesis, we have used ASC differentiation from proliferation to adipocytes
as a model to study changes in chromatin organization. Our main ﬁndings are
highlighted in the model shown in Figure 16. We report that genes with stronger
expression levels display greater variation of chromatin states. GeneA and GeneB
have weak expression and thus, the loci are occupied by a limited number of his-
tone PTM combinations (chromatin states; Figure 16A). After induction of differ-
entiation, GeneA is strongly expressed, leading to high chromatin state dynamics
of loci with many active chromatin states. In contrast, GeneB becomes repressed
and shows fewer chromatin states; these include repressive modiﬁcations.
We report a method of predicting P-E interactions which reveals constitutive
CTCF counts between an enhancer and promoter as a major factor for identiﬁc-
ation of P-E interactions. In Figure 16A, promoters of both GeneA and GeneB
interact with their cognate enhancers. Active enhancers are marked by H3K4me1,
H3K27ac and CTCF whereas inactive enhancers are only marked by H3K4me1.
Additionally, CTCF counts between interacting P-E pairs are lower than non-
interacting P-E pairs. However, after induction of differentiation, CTCF binding
decreases between GeneA and the newly interacting enhancer. In contrast, CTCF
binding increases between GeneB and the enhancer it lost contact with; resulting
in GeneA gaining a P-E interaction whereas GeneB does not have any P-E inter-
actions. Thus, one enhancer can regulate numerous promoters and at a given point
in time a promoter can interact with multiple enhancers.
We further report that lamin A/C LADs are gene-rich in undifferentiated pro-
liferating or cell cycle-arrested ASCs; LADs extend after cell cycle arrest and
reform non-randomly on GADs after induction of differentiation; in contrast,
GADs are stable during differentiation (Figure 16B). After adipogenic induc-
tion, de novo LADs become gene-poor and transcriptionally repressed. Moreover,
as post-differentiation lamin A/C LADs overlap to greater extent with lamin B1
LADs [86], our results suggest the formation of these de novo lamin A/C LADs
near the nuclear periphery. Our ﬁndings collectively provide new insights on how
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Figure 16: A model for changes in chromatin states and architecture during ASC differentiation.
(A) Increased gene expression is coupled with varied chromatin states in a gene locus. Enhancers
are marked by H3K4me1 while active enhancers harboring H3K27ac in addition. CTCF enrich-
ment at the enhancer along with CTCF counts between a promoter and enhancer inﬂuence P-E
interaction probability. (B) GADs are stable throughout differentiation. LADs are gene-rich in
proliferating cells and expand with cell-cycle arrest. De novo LADs form non-randomly on GADs
upon induction of adipogenesis.
histone PTMs, including domains of H2BS112GlcNAc (GADs), LADs and P-E
interaction together regulate chromatin architecture and gene expression during
stem cell differentiation.
In spite of our new ﬁndings, a number of issues are pending. (i) It remains
unclear whether changes in chromatin states precede gene expression changes or
whether gene expression levels impact local chromatin environment. (ii) Our data
suggest that most of the genome harbors multiple coinciding histone PTMs; it will
be important determine whether multivalency of histone marks does exist. (iii)
We propose a model where GADs may pre-pattern differentiation-driven lamin
A/C-chromatin associations. However, our data are at present correlative and one
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will need to determine whether a functional relationship exists between LADs
and GADs. This may be achieved by showing that removal or genomic displace-
ment of H2BS112GlcNAc would prevent or alter de novo formation of LADs.
A mutational approach can be envisaged, where a non-S112-GlcNAcylable H2B,
such as an H2BS112A mutant, is expressed in order to replace endogenous H2B.
This would enable assessing H2BS112GlcNAc levels and determining the impact
on de novo lamin A/C LAD formation. Along these lines, it remains unknown
whether the rearrangement of lamin A/C LADs is a prerequisite for ASC differ-
entiation or a consequence thereof. (iv) We report that RF can be used to identify
P-E interactions and that CTCF counts between promoters and enhancers are an
important predictor of P-E interaction. How does our prediction relate to single
nucleotide polymorphisms (SNPs) identiﬁed from genome-wide association stud-
ies in relation to genetic diseases? It is also unknown if P-E interactions occur due
to epigenetic patterning or vice-versa.
Recent advances in molecular and cell biology techniques can be applied to
advance our knowledge of epigenetic marking and genome organization. Fluores-
cence tagging of histone PTMs can be applied to track changes in histone PTMs in
vivo [262]. In conjunction with nascent-transcript detection [263] or click chem-
istry [264], this can provide causal insights to the relationship between epigenetic
marking and gene expression. m6A-Tracer-derived techniques [84] and single-cell
Hi-C-based modeling [168] at a high resolution provide information on locus pos-
itioning in the 3D nuclear space. These methods in conjunction with ﬂuorescence
in situ hybridization (FISH) or locus tracking in living cells using Cas9-EGFP
tagging of loci [265] may shed light on the level of synchrony or stochasticity
in chromatin organization as it relates to transcriptional status of individual loci
in single cells. The parallel development of molecular techniques and of increas-
ingly tailored and performant bioinformatic tools will lead to better understanding
of chromatin regulation in dynamic systems.
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